A Phase 1 Pilot Comparison Study of 99mTc-MIP-1404 Single Photon Emission Computed Tomography (SPECT)/CT Imaging to Histology in Men With Prostate Cancer
Interventional
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Tissue distribution of 99mTc-MIP-1404 SPECT/CT imaging in tumor and non-tumorous regions of the prostate
Tissue distribution of 99mTc-MIP-1404 SPECT/CT imaging in tumor and non-tumorous regions of the prostate (as determined by histopathology) in patients undergoing standard of care prostatectomy
Within 3-6 hours of dosing SPECT/CT images will be taken
No
Kevin Slawin, M.D.
Principal Investigator
Vanguard Urologic Research Foundation, University of Texas, Houston
United States: Food and Drug Administration
MIP-1404-105
NCT01615406
April 2012
Name | Location |
---|---|
The University of Texas Health Science Center - Houston | Houston, Texas 77030 |